Boothbay Fund Management’s Bluejay Diagnostics BJDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-6,783
Closed -$32.6K – 2106
2026
Q2
$32.6K Buy
+6,783
New +$70.2K ﹤0.01% 2130

Other funds holding BJDX

Boothbay Fund Management's BJDX Position: Q3 2026 in Review

Boothbay Fund Management sold out of Bluejay Diagnostics (BJDX) in Q3 2026, closing a stake of 6,783 shares — an estimated $32.6K sold.

Boothbay Fund Management first reported a position in BJDX in Q2 2026 and held it in 1 quarter. The position peaked at $32.6K in Q2 2026. 13 funds tracked by Wall St. Rank hold BJDX as of Q3 2026.

  • Boothbay Fund Management reported no remaining Bluejay Diagnostics position as of Q3 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 6,783 Bluejay Diagnostics shares in Q3 2026, an estimated $32.6K.
  • Boothbay Fund Management first reported a position in Bluejay Diagnostics in Q2 2026 and held it in 1 quarter.
  • Boothbay Fund Management's Bluejay Diagnostics position peaked at $32.6K in Q2 2026.
  • 13 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q3 2026.

Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.